Home
Storia in 1 fonti
What is pulmonary hypertension and why would a new GLP-1 help?
A report about unusual access to an experimental obesity drug has raised interest in the condition pulmonary hypertension.
Raccontata da
statnews.com
Timeline cronologica
- ·
Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use”…
- ·
Lilly's retatrutide has been offered to a single person via 'compassionate use' program
The "triple-G" weight loss drug, Pfizer's lung cancer trial results, and more biotech news from The Readout
- ·
What is pulmonary hypertension and why would a new GLP-1 help?
A report about unusual access to an experimental obesity drug has raised interest in the condition pulmonary hypertension.